16 The earliest interim efficacy results from the first 800 patients enrolled, released in April 2025, 17 showed that 534 patients received once-weekly subcutaneous semaglutide 2.4 mg and 266 received placebo
Last month, another study published in the journal Addiction illustrates similar findings: medications like Ozempic were associated with lower rates of opioid overdose among people with opioid use disorder and lower rates of alcohol use among people with alcohol use disorder
People with diabetes are at risk for not only diabetic retinopathy but also the development of conditions, such as cataracts, glaucoma and dry eye
Its worth noting that comparing results across weight loss trials can be difficult, since studies often include different patient populations, treatment durations, dosing schedules, and study methods
Other potential effects include flushing, increased heart rate, headache, lightheadedness, and GH-axis-related effects such as fluid retention or joint discomfort